The largest database of trusted experimental protocols

Anti gapdh 0411

Manufactured by Santa Cruz Biotechnology
Sourced in United States

Anti-GAPDH (0411) is a primary antibody produced by Santa Cruz Biotechnology. It is designed to detect the GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase) protein, which is a widely used housekeeping gene and protein for normalization in various biological assays.

Automatically generated - may contain errors

5 protocols using anti gapdh 0411

1

Western Blotting of AR and Housekeeping Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed as previously described [25 (link)] with minor modifications. Briefly, tissue samples or cell line pellets were homogenized in 500 ul RIPA Lysis and Extraction Buffer (Thermo Fisher Scientific Inc.) supplemented with protease inhibitors (Thermo Fisher Scientific Inc.). The protein concentration was determined according to the Bradford protein assay (Bio-Rad, Richmond, CA, USA). Tissue/cell line lysates containing 100ug protein were separated on 4%-20% Tris-Glycine SDS-PAGE gel (Thermo Fisher Scientific Inc) and assessed according to Western blot analysis, and sequential probing with a polyclonal antibody against AR (N20, 1:200 dilution); a monoclonal anti- GAPDH (0411, diluted 1:10000) (Santa Cruz Biotechnologies, Santa Cruz, CA, USA,) or anti-β-Actin (AC-74 diluted 1:5000) (Sigma-Aldrich), as indicated, and with the relevant secondary horseradish peroxidase-conjugated antibody (Santa Cruz Biotechnologies).
+ Open protocol
+ Expand
2

Protein Expression Analysis by Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed by an RIPA buffer for 30 min at 4 °C. A total of 25 µg of protein extracts were resolved by SDS–PAGE and blotted to nitrocellulose membranes (Invitrogen, Thermo Fisher Scientific Waltham, MA, USA ) and probed with the following antibodies (all 1:1000): anti-EZH2 (D2C9); anti-PLK1 (208G4); anti-ERK1/2 (137F5); anti-P-ERK1/2 (Thr202/tyr204); anti-H3 (D1H2); anti-H3K27me3 (C36B11) (all Cell Signaling Technology, Leiden, The Netherlands); and anti-GAPDH (0411) (Santa Cruz, Dallas, TX, USA). Antibody incubation was performed in 5% milk (Carl Roth, Karlsruhe, Germany) or bovine serum albumin (BSA (Merck, Darmstadt, Germany)) at 4 °C overnight. For antibody detection, blots were incubated for 1 h at room temperature with m-IgGκ BP-HRP (1:5000) (Santa Cruz, Dallas, TX, USA) or anti-rabbit IgG-HRP (1:2000) (Cell Signaling Technology, Leiden, The Netherlands). Chemiluminescent detection was performed using Amersham ECL Prime (GE Healthcare, Amersham, UK).
+ Open protocol
+ Expand
3

Antibodies for Western Blot and Immunofluorescence

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibodies used in this study were obtained from the following sources: anti-survivin (71G4B7, Cat#2808), anti-XIAP (3B6, Cat#2045), anti-phospho-JAK1 (Y1034/1035; Cat#3331), anti-phospho-STAT3 (Y705; D3A7, Cat#9145), anti-cleaved PARP (Cat#5625T), anti-cleaved caspase 3 (Cat#9664) and anti-phospho-JAK2 (Y1007/1008; Cat#3771) from Cell Signaling Technology Inc. (Beverly, MA, USA); anti-actin (I-19, Cat#sc-1616), anti-GAPDH (0411, Cat#sc-47724), anti-JAK1 (B-3, Cat#376996), anti-phospho-STAT3 (Y705; B-7, Cat#sc-8059), anti-STAT3 (F-2, Cat#sc-8019), from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA); anti-vinculin (Cat#V-4505) from Sigma-Aldrich. Antibody binding was detected with donkey anti-mouse IgG-HRP (Cat#A16017), donkey anti-rabbit IgG-HRP (Cat#A16029) and donkey anti-goat IgG-HRP (Cat#A15999) from Thermo Fisher Scientific Inc. (Waltham, MA, USA); Alexa Fluor™ 488-conjugated donkey anti-mouse (Cat#A31572, Molecular Probes, Eugene, OR, USA) was used for antibody binding detection in immunofluorescence assays.
+ Open protocol
+ Expand
4

Immunofluorescence and Proximity Ligation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
After fixation in 4% paraformaldehyde/PBS and permeabilization, cells were incubated with antibodies diluted in PBS containing 1% BSA (Nacalai) and 0.02% Tween‐20 for 1 h. Nuclear staining was performed using DAPI (Dojindo). Images of stained cells were acquired with a laser confocal microscope (Carl Zeiss LSM710 and LSM800 or Olympus FV3000). In case of CXCL12 treatment, cells were cultured in DMEM supplemented with 0.05% BSA and treated with 100 ng/ml CXCL12. The proximity ligation assay (PLA) of transfected Cos7 cells was done using anti‐Halo rabbit antibody (Promega) and anti‐FLAG M2 mouse antibody (Sigma‐Aldrich) along with Duolink PLA kit (Sigma‐Aldrich) according to the manufacture’s protocol. The used antibodies were as follows: anti‐X123 (3C7), anti‐Epsin1 (C‐11), anti‐CXCR4 (12G5), and anti‐GAPDH (0411) antibodies (Santa‐Cruz Biotechnology); anti‐Clathrin (D3C6), anti‐Rab5 (E6N8S), anti‐Rab7 (D95F2), anti‐Rab11 (D4F5), anti‐ITCH (D8Q6D), anti‐HA tag, anti‐FLAG (DYKDDDDK), and anti‐Myc tag antibodies (Cell Signaling Technology); anti‐CXCR4 antibody (Abcam); anti‐ubiquitin (FK2) antibody (MBL); specific secondary antibodies conjugated to Alexa Fluor 350, 488, 555 or Alexa Fluor Plus 647 (Invitrogen).
+ Open protocol
+ Expand
5

Ubiquitin Signaling in HEK293T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human embryonic kidney (HEK) 293T cells were cultured in Dulbecco’s Modified Eagles Medium (DMEM, Hyclone) supplemented with 1% penicillin/streptomycin (P/S) and 10% fetal bovine serum (Hyclone). Predesigned siRNA duplexes were purchased from Bioneer, and 10 nM siRNA transfection was carried out using RNAiMAX (Invitrogen, Waltham, MA, USA). Cells and tissues were lysed with N-PER™ and T-PER™ lysis buffer (Thermo Scientific, Waltham, MA, USA) supplemented with protease inhibitor cocktail (Roche, Hoffmann-La Roche AG, Basel, Switzerland), respectively. Lysates were resolved by SDS-PAGE gels and transferred onto nitrocellulose (NC) membranes (Merck Millipore, Burlington, MA, USA), and then antibodies were detected using the D-Plus ECL Femto System (Dongin Bio, Seoul, Korea) and the ImageQuant LAS4000 (GE Healthcare, Chicago, IL, USA). Antibodies used for immunoblotting included the following: anti-Ubiquitin (P4D1, Santa Cruz, Santa Cruz Biotechnology, Dallas, TX, USA), anti-UBE2H (18-Z, Santa Cruz), anti-Parkin (PRK8, Santa Cruz), anti-GAPDH (0411, Santa Cruz), anti-β-actin (C4, Santa Cruz), anti-Tau (Abcam, Cambridge, UK), and anti-UBE2L6 (MyBioSource, San Diego, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!